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Abstract
Background: Human cryptococcal infections have been associated with bird droppings as a likely source of infection.
Studies toward the local and global epidemiology of Cryptococcus spp. have been hampered by the lack of rapid,
discriminatory, and exchangeable molecular typing methods.
Methodology/Principal Findings: We selected nine microsatellite markers for high-resolution fingerprinting from the
genome of C. neoformans var. grubii. This panel of markers was applied to a collection of clinical (n = 122) and environmental
(n = 68; from pigeon guano) C. neoformans var. grubii isolates from Cuba. All markers proved to be polymorphic. The
average number of alleles per marker was 9 (range 5–51). A total of 104 genotypes could be distinguished. The
discriminatory power of this panel of markers was 0.993. Multiple clusters of related genotypes could be discriminated that
differed in only one or two microsatellite markers. These clusters were assigned as microsatellite complexes. The majority of
environmental isolates (.70%) fell into 1 microsatellite complex containing only few clinical isolates (49 environmental
versus 2 clinical). Clinical isolates were segregated over multiple microsatellite complexes.
Conclusions/Significance: A large genotypic variation exists in C. neoformans var. grubii. The genotypic segregation
between clinical and environmental isolates from pigeon guano suggests additional source(s) of human cryptococcal
infections. The selected panel of microsatellite markers is an excellent tool to study the epidemiology of C. neoformans var.
grubii.
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Introduction
Cryptococcosis ranks as one of the three common life-
threatening opportunistic infections in persons with AIDS [1].
Global estimates indicate more than 900,000 annual cases, causing
an estimated 624,700 deaths [2]. Other patient groups with
impaired T-cell function have an up to 6% lifetime risk of
developing clinically manifest cryptococcosis [3]. Seventy species
belonging to the genus Cryptococcus have been described, but only
members of the C. neoformans complex are mostly associated with
human infections. This species complex has been considered to
contain two pathogenic species: C. neoformans involving the varieties
neoformans (serotype D) and grubii (serotype A), and C. gattii
(serotypes B and C) [4–7]. Six monophyletic lineages have been
identified that also may represent species [4,5,8] as well as some
hybrids [9–12].
In the Caribbean the disease appears to be not very common
with an estimated 7800 patients and 4300 casualties reported
annually [2]. In Cuba the disease was first reported in the early
1950s [13]. Since then sporadic cases of cryptococcosis were
associated with alcoholism, organ transplants and immunological
disorders. Since the first cases of AIDS in Cuba in 1986, the
number of patients infected by this fungus has increased over the
years. The annual number of infected individuals ranged from 8 to
15 cases per year [14] while a study of 211 serial autopsies of
patients with HIV/AIDS infection in Cuba over a period of 10
years, showed that systemic or central nervous system cryptococ-
cosis was a serious and common disorder in 29% of cases [15]. Up
to now all clinical isolates from patients in Cuba have been
identified as C. neoformans var. grubii [16].
Multiple molecular typing methods have been described to
study the epidemiology of C. neoformans complex. The most
commonly used approaches to date involve AFLP, PCR
fingerprinting and or PCR-RFLP approaches as well as mating-
and/or serotype-specific PCRs [17–23]. These techniques have
proven useful to discriminate between the different sero- and
mating types but have not been shown to be very useful for
discrimination within specific C. neoformans complex members and
varieties. Multi-locus sequence typing (MLST) has been applied to
collections of C. neoformans and C. gattii from various origins
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[5,24,25] but this technique is laborious, has a long turn-around
time and is associated with significant costs. Microsatellites are
increasingly popular molecular typing targets since they provide
cost-effective genotyping with fast turn-around times. On a
theoretical basis, and, as has been shown for other fungi,
molecular typing by using microsatellites is more discriminatory
than by using MLST [26]. Like MLST data, microsatellite typing
data is transportable and exchangeable [27]. Here we describe the
use of a 9-marker microsatellite panel consisting of 3 dinucleotide
repeat markers, 3 trinucleotide repeat markers and 3 tetranucle-
otide repeat markers. Each panel of 3 markers was amplified using
a multiplex multicolor PCR approach. Amplified products were
analyzed on a high resolution capillary electrophoresis platform
allowing precise determination of repeat numbers in each marker.
We applied this panel to a collection of clinical and environmental
C. neoformans var. grubii isolates from Cuba. Part of this work was
presented at the 46th Interscience Conference on Antimicrobial
Agents and Chemotherapy (ICAAC), San Francisco, 2006, Abstr.
M904.
Materials and Methods
Ethics Statement
This research was approved by the Institutional Scientific and
Ethical Committee of the Instituto Pedro Kouri, Havana, Cuba.
All data were analyzed anonymously.
Isolates
A total of 190 clinical and environmental Cryptococcus isolates
from the collection of the mycology laboratory at the Tropical
Medicine Institute ‘‘Pedro Kourı´’’, were included in the study.
Clinical strains (n = 122) were collected between 1987 and 2007,
the large majority (91%) of isolates were from cerebrospinal fluid.
The remaining isolates were from urine, blood, tissue biopsy and
bronchoalveolar lavage samples. For ,70% of all clinical isolates,
information about the origin of the patients was available. Most
patients (,65%) were from Havana City. The remaining patients
inhabited almost every province of Cuba (Figure 1). Approxi-
mately 77% of all patients were HIV positive. All clinical isolates
were from different patients. Environmental isolates (n = 68) were
isolated from pigeon guano collected in the period 1998 to 2007
from well distributed locations across Cuba (Figure 1). In case an
environmental sample yielded multiple different colony morphol-
ogies suspected of being Cryptococcus, these were analyzed
separately.
Species identification was initially performed by standard
mycological methods [28] and confirmed with a commercial
identification system (Auxacolor 2; Bio-Rad, Marnes-la-Coquette,
France) as well as by using AFLP analysis.
DNA Isolation
A suspension of freshly grown cells was prepared in lysis buffer
(Roche Diagnostics, Almere, The Netherlands) and subjected to
mechanical lysis in a MagNA Lyser for 30 s at 6500 rpm (Roche
Diagnostics). Next, DNA was purified using a MagNAPure LC
instrument in combination with a MagNAPure LC DNA Isolation
Kit III as recommended (Roche Diagnostics). DNA yield and
purity were estimated by UV absorbance measurements.
Microsatellite Analysis
Candidate short tandem repeat markers were identified in the
available genomic sequences from the H99 strain using the
Tandem Repeats Finder software [29]. A 9 marker microsatellite
panel consisting of 3 dinucleotide repeat markers, 3 trinucleotide
repeat markers and 3 tetranucleotide repeat markers was selected
from the candidate markers using previously described criteria
[30]. PCR amplification primers for each of the markers are
according to Table 1. Three subpanels (CNA2, CNA3 and CNA4
respectively) of 3 markers each were amplified using a multicolor
multiplex PCR approach. Within each panel, one of the
amplification primers carried a fluorescent label consisting of
either FAM (6-carboxyfluorescein), HEX (hexachlorofluorescein)
or TET (tetrachlorofluorescein). In addition to the amplification
primers, each 50 ml amplification reaction contained approxi-
mately 1 ng of genomic DNA, 1 U FastStart Taq DNA
polymerase (Roche diagnostics), 2 mM MgCl2 and 0.2 mM
dNTP’s in 1x reaction buffer (Roche diagnostics). The amplifica-
tion profile consisted of a 10 min denaturation/activation step
followed by 35 cycles of 94uC for 30 s, 60uC for 30 s and 72uC for
1 min. After an additional 10 min incubation at 72uC, the
reactions were cooled to room temperature.
AFLP Analysis
Approximately 50 ng of genomic DNA was subjected to a
combined restriction-ligation procedure containing 5 pmol of
EcoR I adapter, 50 pmol Mse I adapter, 2 U of EcoR I (New
England Biolabs, Beverly, MA, USA), 2 U of Mse I (New England
Biolabs) and 1 U of T4 DNA ligase (Promega, Leiden, The
Netherlands) in a total volume of 20 ml of 1x reaction buffer for
1 hour at 20uC. Next, the mixture was diluted five times with
10 mM Tris/HCl pH 8.3 buffer. Adapters were made by mixing
equimolar amounts of complementary oligonucleotides (59-
CTCGTAGACTGCGTACC-39 and 59-AATTGGTACGCAG-
TC-39 for EcoR I; 59-GACGATGAGTCCTGAC-39 and 59-
TAGTCAGGACTCAT–39 for Mse I) and heating to 95uC,
subsequently followed by cooling slowly to ambient temperature.
One microliter of the diluted restriction-ligation mixture was used
for amplification in a volume of 25 ml under the following
conditions: 1 mM EcoR I primer with two selective residues (59-
Flu-GTAGACTGCGTACCCGTAC-39), 1 mM MseI primer
with one selective residues (59-GATGAGTCCTGACTAAG-39),
0.2 mM each dNTP and 1 U of Taq DNA polymerase (Roche
Diagnostics) in 1x reaction buffer containing 1.5 mM MgCl2.
Amplification was done as follows. After an initial denaturation
step for 4 min at 94uC in the first 20 cycles a touch down
procedure was applied: 15 s denaturation at 94uC; 15 s annealing
at 66uC with the temperature for each successive cycle lowered by
0.5uC and 1 min of extension at 72uC. Cycling was then
continued for further 30 cycles with an annealing temperature of
56uC. After completion of the cycles an additional incubation at
72uC for 10 min was performed before the reactions were cooled
to room temperature. The amplicons were then combined with
the ET400-R size standard (GE Healthcare, Diegem, Belgium)
and analyzed on a MegaBACE 500 automated DNA platform
(GE Healthcare), according to the manufacturer’s instructions.
Capillary Electrophoresis
Following amplification, the reaction products were diluted 10-
fold with distilled water. One ml of diluted products was combined
with 0.25 ml of ET-ROX 550 size marker and 8.75 ml of distilled
water. After a 1 min denaturation step at 94uC, the samples were
quickly cooled to room temperature and injected onto a
MegaBACE 500 automated DNA analysis platform equipped
with a 48 capillary array as recommended by the manufacturer
(GE Healthcare). Electropherograms were analyzed using Frag-
ment Profiler 1.2 software (GE Healthcare). Assignment of repeat
numbers was relative to the results obtained using the H99 strain,
which was used as a control strain in all experiments. According to
C. neoformans var grubii Types
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Figure 1. Origin of samples and relationships between genotypes. A: Map of Cuba. Colored dots indicate provinces from which clinical and/
or environmental samples were available. B: Minimum spanning tree (MST) based on a multistate categorical analysis representing the genotypes of
190 C. neoformans var. grubii isolates from Cuba. Each circle represents a unique genotype. The size of the circle corresponds to the number of
isolates with that genotype. Genotypes are linked to their closest relative. Numbers and connecting lines correspond to the number of different
markers between genotypes. Genotypes with identical colors and connected by a shaded background are part of a microsatellite complex (MC). In
yellow are unique genotypes that are not part of a MC. C: Same as B, but now showing cross-links between all genotypes that differ in no more than 2
markers. D: Same MST as in B, but now showing genotypes obtained from clinical and environmental samples.
doi:10.1371/journal.pone.0009124.g001
C. neoformans var grubii Types
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the genomic sequence, the genotype of the H99 strain was 27-20-
20-57-17-14-55-19-16 for markers 2A-2B-2C-3A-3B-3C-4A-4B-
4C respectively.
Data Analysis
Typing data was imported into BioNumerics v5.0 software
(Applied Maths, Sint-Martens-Latem, Belgium). Microsatellite
data was analyzed using the multistate categorical similarity
coefficient. Microsatellite complexes (MC’s) were defined as
groups of 2 or more genotypes differing by a maximum of 2
markers. AFLP data was analyzed by UPGMA clustering using
the Pearson correlation coefficient.
Results
A selection of 9 microsatellite markers was made from genomic
sequences from Cryptococcus neoformans var. grubii strain H99. All
markers proved to be polymorphic displaying a minimum of 5 and
up to 51 different alleles per marker (Table 1). The specificity of
the markers was tested by including C. neoformans var. neoformans
isolates (serotype D) as well as C. gattii isolates (serotype B). None of
these isolates yielded amplification products confirming the
specificity of these primers for C. neoformans var. grubii.
In Table 2, the discriminatory power for each of the individual
markers, panels and entire set of markers were calculated. When
all markers are combined, the nine marker microsatellite panel
yielded a discriminatory power of greater than 0.993. With this
collection of 190 isolates, 104 different genotypes could be
discriminated. The AFLP analysis confirmed that all isolates were
C. neoformans var. grubii (not shown) in line with previous
observations [16]. This panel of markers thus provides a highly
discriminatory typing assay for C. neoformans var. grubii. The
relationship between the different genotypes is illustrated in
Figure 1. Within the large diversity of genotypes, complexes of
closely related genotypes are recognized and indicated as
microsatellite complexes (MC’s). Within the MC’s most of the
genotypic variation is the result from variations in few microsat-
ellite markers (Table 3). The most discriminatory marker was
marker CNA4a. Elimination of this marker from the dataset
resulted in a reduction of the number of different genotypes by
approximately 50%, but did not affect the distribution of the
isolates over the different MC’s nor did it affect the segregation
between the different MC’s (results not shown). Eleven MC’s are
recognized containing up to 51 isolates each. Nine further
genotypes (from 18 isolates) were observed that did not belong
to a microsatellite complex, bringing the total number of different
genogroups to 20. Four MC’s (MC1-MC4) were the most
prevalent and contain more than 70% of all isolates.
Not all markers yielded a PCR product with all of the isolates,
especially markers CNA3a scored negative on a substantial part
(85%) of the isolates. When a negative result was obtained, the
particular marker was reamplified in a monoplex PCR reaction.
When still negative, the marker was scored as ‘‘0’’. Exclusion of
marker CNA3a from the microsatellite panel did not influence the
clustering of the isolates over the different MC’s (not shown).
The distribution of the clinical and environmental isolates over
the different MC’s is shown in Table 4. Very interestingly, MC1
contained a large majority of isolates from environmental origin
(.96% from pigeon guano) and only few human clinical isolates.
This difference was highly significant (p,0,001). Though small in
size, MC9 also exclusively contained isolates from environmental
origin . The non environmental MC’s were all found in HIV
positive patients with one exception: MC6 contained 3 isolates and
those were obtained from HIV negative patients.
The temporal distribution of the largest MC’s with clinical
isolates showed their presence over prolonged periods of time since
Table 1. Basic characteristics of the selected microsatellite markers.
Panel Marker Chr: position
Repeat
unit
Labeled primer
sequence (59-39)
Unlabeled primer
sequence (59-39)*
Conc.
(mM)
No. alleles
(range)
CNA2 CNA2A 11: 389201–389350 CT FAM- CGAGGTCATGTTGTGAGTCC GTGACCGTCTCGTTCTTCTCA 0.3 15 (10–60)
CNA2B 9: 191563–191711 TG HEX- TCGTCAACGATGCAAGTCTC GGGCCTGGGAAATAGGTAGA 0.3 6 (8–21)
CNA2C 10: 307773–306912 TA TET- AGAAGCACATGGGGAAAGG GCGCAGTTTGAAGATGAGAA 1.0 16 (8–44)
CNA3 CNA3A 11: 1281429–12814716 CTA FAM- ACCCCCTGCCCATCATA GCACAGGCATAAAGCTAAGTGTGA 0.3 9 (19–69)
CNA3B 4: 339525–339664 TCT HEX- TGGGGATATCGATTCCTTCTC GATTGGTATGGGAAGCGTTG 0.3 5 (5–17)
CNA3C 7: 285123–285270 CCA TET- TGGAAGAGGATGGAGCGTAT GCATAGTTTATCGTTTTCTCTTTTC 0.3 10 (8–38)
CNA4 CNA4A 5: 233120–233445 TTAT FAM- CGTCGAAGACTGCACAAAAA GTTCTGTATGACAGGTCGCAAA 1.0 51 (15–119)
CNA4B 4: 1021855–1022020 ATCC HEX- CGGATGAGATGGAAAGAAGG GTGCGTCTGTCAAAAGATTGC 0.3 10 (5–25)
CNA4C 14: 131866–132031 TATT TET- AGATGTCCTGGCGATGTTG GAGGAGCAAGCAATCAAACC 0.3 11 (1–18)
*The underlined residue(s) are not a match to the genomic sequence. These were introduced to minimize the formation of minus A peaks, a well known PCR artifact that
may complicate interpretation of the results [34].
doi:10.1371/journal.pone.0009124.t001
Table 2. Overview of the discriminatory power of the
individual markers, panels of markers and the entire set of
markers. Calculated values are based on the Simpson’s index
of diversity and are expressed in a value of ‘D’ [35].
Marker D Panel D Set D
CNA2a 0.842 CNA2 0.906 CNA 0.993
CNA2b 0.789
CNA2c 0.828
CNA3a 0.282 CNA3 0.868
CNA3b 0.618
CNA3c 0.819
CNA4a 0.972 CNA4 0.992
CNA4b 0.712
CNA4c 0.688
doi:10.1371/journal.pone.0009124.t002
C. neoformans var grubii Types
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they were found repeatedly since the early years of the study and
thus have been present for almost 2 decades.
Discussion
A 9-marker microsatellite panel is described for high resolution
sub typing of C. neoformans var. grubii isolates, one of the members
of the C. neoformans complex, in particular serotype A isolates. This
panel of markers provides a highly discriminatory panel allowing
excellent discrimination between isolates from various origins. The
numerical typing result allows easy storage into global databases as
well as portability of the results.
From the results, it is obvious that certain genotypes appear to
be more closely related to each other than to other genotypes.
MC’s were arbitrarily defined by genotypes differing in up to 2
microsatellite markers from each other. Within each MC, the
amount of variation is attributable to only one or two
microsatellite markers as the likely result of instability of these
specific markers. This mostly involved the markers CNA2a,
CNA2c and CNA4a. Not surprisingly, these are among the most
discriminatory markers from the entire set (Table 2). Likewise,
within an MC, there was very limited to no variation in the less
discriminatory markers (Table 3). The difference between the
MC’s is attributable to multiple microsatellite markers ($3
markers difference). Although MC1 and MC2 could be connected
to each other by sequential genotypes differing in only 2
microsatellite markers, there appears to be no close relationship
between these MC’s (Figure 1C; Table 3) and these were therefore
considered to reflect different unrelated MC’s.
One marker that was selected from the H99 genome (CNA3a)
did not yield an amplification product in 85% of all tested isolates.
This could be the result of an actual deletion of this locus in the
genome from these isolates or it could be the result of one or more
sequence polymorphisms underneath either of the two amplifica-
tion primers. Alternatively, the size of the amplified fragment
could be beyond the reach of the size marker on the capillary
electrophoresis runs. This was not further investigated. Whether or
not this observation is specific for the Cuban population of C.
neoformans var. grubii, which may very well be explained by the
geopolitical isolation of this country, remains to be established.
In our study, the large majority of environmental isolates from
pigeon droppings co-clustered in one MC (MC1) containing only
very few isolates from human clinical samples. This MC was
widespread in multiple environmental locations across Cuba. Vice
versa, several of the other MC’s predominantly contained isolates
from human clinical samples and only few from environmental
origin. Possibly, isolates from MC1 are more adapted to the
pigeon host and may be less pathogenic for humans. Several MC’s
were identified that contained only clinical isolates and were never
found in environmental samples which suggests the presence of
additional niches of C. neoformans var. grubii that may cause human
infections. One MC was identified (MC6) containing only isolates
Table 3. Signature profiles of the 4 most prevalent microsatellite complexes and the reference isolate H99 upon whose genome
the selection of markers was made.
CNA2a CNA2b CNA2c CNA3a CNA3b CNA3c CNA4a CNA4b CNA4c
MC1 53–60 11 9 0 13 35–38 85–108 8 5
MC2 11 8 22–25 0 14 16 30–37 8 5
MC3 10 12 10 0 14 14 66–78 6 9–11
MC4 12 10 8 0 5 8 103–119 5 1
H99 27 20 20 57 17 14 55 19 16
doi:10.1371/journal.pone.0009124.t003
Table 4. Distribution of isolates from clinical (including HIV status) or environmental origin over the 11 microsatellite complexes.
Complex Total number of isolates Env. Clin. HIV pos. HIV neg. HIV status unknown
MC1 51 49 2 2 0 0
MC2 32 2 30 16 6 8
MC3 39 2 37 27 9 1
MC4 14 0 14 14 0 0
MC5 8 2 6 5 0 1
MC6 3 0 3 0 3 0
MC7 9 5 4 4 0 0
MC8 4 1 3 3 0 0
MC9 3 3 0 0 0 0
MC10 2 0 2 1 1 0
MC11 7 0 7 4 1 2
other 18 4 14 9 5 0
Total 190 68 122 85 25 12
Env.: Environmental isolates; Clin.: Clinical isolates; pos.: positive; neg.: negative.
doi:10.1371/journal.pone.0009124.t004
C. neoformans var grubii Types
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from humans without HIV infection. This may indicate that this
particular genotype may be more virulent to humans but this
clearly needs more confirmation. However, despite careful
selection of multiple colonies from environmental samples, we
cannot rule out the possibility that there could have been a
sampling bias towards genotypes that are more abundantly present
in pigeon guano.
In this study, we used AFLP analysis for a dual purpose. Firstly
to confirm the identification of the isolates as C. neoformans var.
grubii, and secondly to validate the typing result of the
microsatellite analysis. The specific combination of restriction
enzymes and selective residues used here was reported before [17].
Interestingly, we found only limited genetic variation in this
collection of isolates. AFLP showed no segregation between the
isolates in MC1 and the majority of the other isolates (results not
shown). On the other hand, a relatively small number of clinical
isolates (11%) did indeed segregate into a separate AFLP cluster.
This subdivision is fully supported by the microsatellite data since
this AFLP cluster is recognized as a separate MC (MC4, Figure 1),
well separated from the other MC’s. Since AFLP analysis amplifies
fragments from multiple random locations in the genome, this may
point to relatively few or small genomic differences between MC1
isolates and the majority of the other isolates versus substantial
genomic differences between the majority of the isolates and those
from MC4. Probably, the discriminatory power of the AFLP
analysis can be increased by testing other combinations of
restriction enzymes and/or selective residues but this was not
attempted.
C. neoformans var. grubii has since long been associated with bird
droppings: according to the Centers for Disease Control and
Prevention, people with weakened immune systems should avoid
areas contaminated with bird droppings and contact with birds
[31]. However, this assumed link has received little attention using
molecular typing studies. Our results suggest that certain clinical
isolates may originate from additional ecological niche(s). This is
supported by recent evidence from Litvintseva et al. that
environmental isolates from pigeon excreta were less pathogenic
in a mouse model than isolates from human clinical samples [32].
In this prior work, neither AFLP nor MLST proved useful to
distinguish between these clinical and environmental isolates.
Instead, a retrotransposon based Southern blotting procedure
enabled them to distinguish between individual isolates with
identical AFLP/MLST genotypes. However, analysis of serial
cultures showed that the genotypes were not stable over time,
limiting the usefulness of this approach. In addition, the authors
did not report specific genotypes being associated with either
clinical or environmental isolates. Our results confirm the
superiority of this panel of microsatellite markers as molecular
typing targets for C. neoformans var. grubii and simultaneously allow
distinguishing between isolates from clinical and environmental
origin. The lack of temporal and spatial (east to west Cuba is
1000 km) variability suggest a clonal relationship between the
majority (.70%) of isolates from pigeon guano in Cuba. This too
may be explained by the isolated location of the country. In
contrast, most clinical cases were from Havana City and these
involved multiple different MC’s additionally suggesting the
presence of alternative sources for human infections.
The use of microsatellite markers in typing studies with C.
neoformans var. grubii was reported before. Hanafy et al. reported a
selection of 15 microsatellite markers for C. neoformans var. grubii of
which only 3 proved to be polymorphic [33]. The PCR products
were analyzed by agarose gel electrophoresis. This technique
suffers from insufficient resolution and does not allow use of the
full potential of microsatellite markers as molecular typing targets.
In summary, we have developed a novel approach for high
resolution molecular sub typing of C. neoformans var. grubii. This will
help the study of the global epidemiology of this opportunistic
pathogenic yeast. We also show that microsatellites are excellent
multilevel genotyping targets allowing recognition of individual
genotypes as well as clusters of related genotypes. The selected
microsatellite markers are sufficiently stable for use in long-term
longitudinal studies. Finally, our results point to additional sources
other than bird droppings as origin of human infections.
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